On July 1st, 2024, jd health announced that it had granted about 1,103,816 incentive shares to group employees (excluding directors and senior managers) under the stock incentive plan after the initial public offering, accounting for about 0.03% of the total issued shares. The market price of the award shares is HKD 21.25 per share, and the consideration for granting the shares is zero. The attribution period varies, ranging from a minimum of 0.5 years to a maximum of 4 years. The grant is aimed at encouraging employees to align their interests with those of the company and contribute to its long-term growth. If the incentive shares granted are not attributed under certain conditions, they will be immediately confiscated or canceled. The new shares will have equal rights as the already issued shares, but the trustee will not exercise any voting rights. As of the date of this grant, there are still 248,985,294 incentive shares available for future grants under the plan.

On July 1st, 2024, jd health announced that it had granted about 1,103,816 incentive shares to group employees (excluding directors and senior managers) under the stock incentive plan after the initial public offering, accounting for about 0.03% of the total issued shares. The market price of the award shares is HKD 21.25 per share, and the consideration for granting the shares is zero. The attribution period varies, ranging from a minimum of 0.5 years to a maximum of 4 years. The grant is aimed at encouraging employees to align their interests with those of the company and contribute to its long-term growth. If the incentive shares granted are not attributed under certain conditions, they will be immediately confiscated or canceled. The new shares will have equal rights as the already issued shares, but the trustee will not exercise any voting rights. As of the date of this grant, there are still 248,985,294 incentive shares available for future grants under the plan.